According to China's top economic planning body, some local companies are cutting back on their efforts to hire new university graduates.China Economyread more
German Chancellor Angela Merkel has presided over a tumultuous recent period, which for many, has left Europe on the brink.Commentaryread more
Tensions between China and the U.S. are threatening to slow global trade further, threatening some Asian economies.Asia Economyread more
U.S. President Donald Trump's former campaign chairman Paul Manafort was transferred to a detention facility in Manhattan on Monday ahead of an expected arraignment on state...White Houseread more
Airbus recorded orders and options for 123 planes, according to the aviation consulting firm IBA.iQ.Paris Air Showread more
Markets in Asia were mostly higher in Tuesday trade as investors awaited the start of a closely-watched meeting by the U.S. Federal Reserve, set to kick off later stateside.Asia Marketsread more
Wall Street analysts think Facebook's cryptocurrency payments project will give the company a big boost.Marketsread more
Chinese President Xi Jinping will travel to North Korea this week for a two-day visit, ahead of a possible meeting between Xi and President Donald Trump at next week's G-20...Politicsread more
The Pentagon said that the crew of one of the tankers, the Japanese Kokuka Courageous, found an unexploded limpet mine on its hull following an initial explosion.Politicsread more
China's Alibaba Group on Tuesday said its chief financial officer, Maggie Wu, will oversee the firm's strategic acquisitions and investments unit, as part of a business and...Technologyread more
Despite the popularity of companies like Beyond Meat and Impossible Foods, meat consumption around the world continues to rise.Food & Beverageread more
Pfizer topped Wall Street estimates for quarterly profit on Tuesday, driven by higher sales of its cholesterol and arthritis drugs, but the biggest U.S. drugmaker lowered its full-year revenue forecast due to a stronger dollar.
The company's rheumatoid arthritis drug, Xeljanz, reported sales of $463 million for the second quarter, beating consensus estimates of $432 million, according to brokerage SunTrust Robinson Humphrey.
Sales of cholesterol-lowering medicine Lipitor came in at $521 million, easily topping estimate of $466 million.
Earlier this month, Pfizer said it would defer price hikes on around 40 of its drugs for no more than six months, after Chief Executive Officer Ian Read spoke with U.S. President Donald Trump.
Since then, other major drugmakers, including Merck & Co , Eli Lilly and Novartis, have made similar announcements.
On Tuesday, Pfizer said it now expects 2018 revenue of between $53 billion and $55 billion, compared with a prior forecast of $53.5 billion to $55.5 billion.
The company is the latest U.S. drugmaker to trim its annual revenue forecast due to a strengthening dollar. Johnson & Johnson also slightly lowered its full-year sales forecast, citing the strong currency.
Pfizer has said it would reorganize itself and create a separate consumer healthcare unit, a business the New York-based company has been trying to sell since last year.
Net income rose 26 percent to $3.87 billion, or 65 cents per share, in the second quarter.
Excluding special items, Pfizer earned 81 cents per share, beating analysts' average estimate of 74 cents, according to Thomson Reuters I/B/E/S.
Revenue rose 4.4 percent to $13.47 billion, ahead of expectations of $13.31 billion.
The company raised its full-year adjusted earnings per share forecast to between $2.95 and $3.05, from $2.90 to $3.00 earlier.
Pfizer said the new forecast reflects $6.1 billion worth of share repurchases already completed in 2018.
Shares of the New York-based company fell slightly to $38.45 in premarket trading.